[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$RGBP $RGBPP Regen BioPharma is presenting at the Emerging Growth Conference on October XX 2025 at 4:10 pm Eastern. We will cover Orphan Drug status and HemaXellerate Clinical Phase I status. Also planning on answering questions from the audience"
X Link @TheRegenBio 2025-10-13T13:57Z 1860 followers, 970.8K engagements
"$RGBP on verge of major event. Text from our update is below: As evidenced by recent comments from Regen on X the company is currently in discussion financing the Phase I clinical trials for HemaXellerate.We infer that management is talking with one or more parties who see the underlying potential of HemaXellerate along with the currently absurdly low valuation. Surely the milestone of coming to an agreement and then closing such a transaction is a major plus for Regen. Thus investors are poised to benefit from potentially substantial future higher price levels. We published an updated report"
X Link @GoldmanSmallCap 2025-10-07T14:44Z 2007 followers, 4400 engagements
"$RGBP $RGBPP The company is currently in discussion on financing the Phase I clinical trials for HemaXellerate"
X Link @TheRegenBio 2025-10-01T16:56Z 1860 followers, 665.7K engagements
"Replay Emerging Growth Conference XX Register for EGC XX Replays available for: $SBC $AUTR $FRSPF $PHOS $TIVC $QQCMF $QQQ $IMRFF $IMR $STKXF $SKP $VANI $LCTC $JAGX $OMEX $MDNAF $MDNA $SRFM $GOVX $SIGY $KSIOF $KSI $ZAPPF $BSAI $USEG $STLNF $STUD $BANL $CIA Cloaked Therapeutics $VROYF $VROY $BNZI $JG $ELRRF $ELO $RGBP To Present: 305-330-1985 Conference@EmergingGrowth.com"
X Link @EmergingGrowthC 2025-09-25T20:50Z 2431 followers, XXX engagements